A suspension induction for myocardial differentiation of rat mesenchymal stem cells on various extracellular matrix proteins

Tissue Engineering - Part C: Methods

Volumn 16, Issue 5, 2010, Pages 979-987

  Miskon, Azizi ^a,b,c   Mahara, Atsushi ^a   Uyama, Hiroshi ^b   Yamaoka, Tetsuji ^a,d  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c UNIVERSITI TUN HUSSEIN ONN MALAYSIA   (Malaysia)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; ENZYME ACTIVITY; FLOWCHARTING; GENE EXPRESSION; MONOLAYERS; POLYMERASE CHAIN REACTION; POLYSTYRENES; PROTEINS; STEM CELLS;

BONE MARROW; BONE MARROW-DERIVED MESENCHYMAL STEM CELLS; CARDIAC MARKERS; CARDIOMYOCYTES; CELL COLONIES; CELL SUSPENSION; COLLAGEN TYPE I; EXTRACELLULAR MATRIX PROTEIN; IMMUNOHISTOCHEMICAL STAINING; IN-VITRO; INDUCTION METHOD; INDUCTION TIME; MESENCHYMAL STEM CELL; MICROENVIRONMENTS; MONOLAYER CULTURE; POLYSTYRENE DISHES; QUANTITATIVE POLYMERASE CHAIN REACTION; SUSPENSION METHODS; TROPONIN T;

CELL CULTURE;

RATTUS;

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; SCLEROPROTEIN;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CYTOLOGY; ENZYMOLOGY; GENETICS; HEART MUSCLE; MALE; MESENCHYMAL STEM CELL; POLYMERASE CHAIN REACTION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CELL DIFFERENTIATION; EXTRACELLULAR MATRIX PROTEINS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; MALE; MESENCHYMAL STEM CELLS; MYOCARDIUM; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 77957331631     PISSN: 19373384     EISSN: 19373392     Source Type: Journal    
DOI: 10.1089/ten.tec.2009.0218     Document Type: Article

References (39)

1. Lopez, A.D., Mathers, C.D., Ezzati, M., Jamison, D.T., and Muray, C.J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367, 1747, 2006.
2. Rose, E.A., Gelijins, A.C., Moskowitz, A.J., Heitjan, D.F., Stevenson, L.W., Dembitsky, W., Long, J.W., Ascheim, D.D., Tierney, A.R., Levitan, R.G., Watson, J.T., Meier, P., Ronan, N.S., Shapiro, P.A., Lazar, R.M., Miller, L.W., Gupta, L., Frazier, O.H., Desvigne-Nickens, P., Oz, M.C., and Poirer, V.L. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) study group. Long-term mechanical left ventricular assistance for the end-stage heart failure. N Engl J Med 345, 1435, 2001.
3. Bank, A.J., Mir, S.H., Nguyen, D.Q., Bolman, R.M., Shumway, S.J., Miller, L.W., Kaiser, D.R., Ormaza, S.M., and Park, S.J. Effects of left ventricular assist devices on outcomes in patients undergoing heart transplantation. Ann Thorac Surg 69, 1369, 2000.
4. Lietz, K., and Miller, L.W. Will left-ventricular assist device therapy replace heart transplantation in the foreseeable future? Curr Opin Cardiol 20, 132, 2005.
5. Miyahara, Y., Nagaya, N., Kataoba, M., Yanagawa, B., Tanaka, K., Hao, H., Ishino, K., Ishida, H., Shimisu, T., Kangawa, K., Sano, S., Okano, T., Kitamura, S., and Mori, H. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat Med 12, 459, 2006.
6. Wollert, K.C., and Drexler, H. Clinical applications of stem cells for the heart. Circ Res 96, 151, 2005.
7. Arnado, L.C., Saliaris, A.P., Schuleri, K.H., St. John, M., Xie, J.S., Cattaneo, S., Durand, D.J., Fitton, T., Kuang, J.Q., Stewart, G., Lehrke, S., Baumgartner, W.W., Martin, B.J., Heldman, A.W., and Hare, J.M. Cardiac repair with intramyocardial injection of allogenic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA 102, 11474, 2005.
8. Jackson, K.A., Majka, S.M., Wang, H., Pocius, J., Hartley, C.J., Majesky, M.W., Entman, M.L., Michael, L.H., Hirschi, K.K., and Goodell, M.A. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107, 1395, 2001.
9. Oakley, R.M.E., Ooi, C.O., Bongso, A., and Yacoub, M.H. Myocyte transplantation for myocardial repair: a few good cells can mend a broken heart. Ann Thorac Surg 71, 1724, 2001.
10. Wakitani, S., Saito, T., and Caplan, A.I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18, 1417, 1995.
11. Makino, S., Fukuda, K., Miyoshi, S., Konishi, F., Kodama, H., Pan, J., Sano, M., Takahashi, T., Hori, S., Abe, H., Hata, J., Umezawa, A., and Ogawa, S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest 103, 697, 1999.
12. Liu, Y., Song, J., Liu, W., Wan, Y., Chen, X., and Hu, C. Growth and differentiation of rat bone marrow stromal cells: does 5-azacytidine trigger their cardiomyogenic differentiation? Cardiovasc Res 58, 460, 2003.
13. Xu, W., Zhang, X., Qian, H., Zhu, W., Sun, X., Hu, J., Zhou, H., and Chen, Y. Mesenchymal stem cell from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med (Maywood) 229, 623, 2004.
14. Clemmons, D.R., Elgin, R.G., Han, V.K., Casella, S.J., D'Ercole, A.J., and Van Wyk, J.J. Cultured fibroblast monolayers secrete a protein that alters the cellular binding of somatomedin-C=insulin-like growth factor I. J Clin Invest 77, 1548, 1986.
15. Griffin, S.J., and Houston, J.B. Prediction of in vitro intrinsic clearance from hepatocytes: comparison of suspensions and monolayer cultures. Drug Metab Dispos 33, 115, 2005.
16. Groothuis, G.M., and Meijer, D.K. Drug traffic in the hepatobiliary system. J Hepatol 24 Suppl 1, 3, 1996.
17. Langer, R., and Vacanti, J.P. Tissue engineering. Science 260, 920, 1993.
18. Boudreau, N.J., and Jones, P.L. Extracellular matrix and integrin signalling: the shape of things to come. Biochem J 339, 481, 1999.
19. Miskon, A., Ehashi, T., Mahara, A., Uyama, H., and Yamaoka, T. Beating behavior of primary neonatal cardiomyocytes and cardiac-differentiated P19. CL6 cells on different extracellular matrix components. J Artif Organs 12, 111, 2009.
20. Huang, N.F., Lee, R.J., and Li, S. Chemical and physical regulation of stem cells and progenitor cells: potential for cardiovascular tissue engineering. Tissue Eng 13, 1809, 2007.
21. Seglen, P.O. Preparation of isolated rat liver cells. Methods Cell Biol 13, 29, 1976.
22. Moldeus, P., Hogberg, J., and Orrenius, S. Isolation and use of liver cells. Methods Enzymol 52, 60, 1978.
23. Stoutamyer, A., and Dhoot, G.K. Transient expression of fast troponin C transcripts in embryonic quail heart. J Muscle Res Cell Motil 26, 237, 2005.
24. Saggin, L., Ausoni, S., Gorza, L., Sartore, S., and Schiaffino, S. Troponin T switching in the developing rat heart. J Biol Chem 263, 18488, 1998.
25. Taylor, S.M., and Jones, P.A. Multiple new phenotypes induced in 10T1=2 and 3T3 cells treated with 5-azacytidine. Cell 17, 771, 1979.
26. Hwang, N.S., Varghese, S., and Elisseeff, J. Controlled differentiation of stem cells. Adv Drug Deliv Rev 60, 199, 2008.
27. Burdick, J.A., and Vunjak-Novakovic, G. Review: engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A 15, 205, 2009.
28. Ebashi, S. Regulatory mechanism of muscle contraction with special reference to the Ca-troponin-tropomyosin system. Essays Biochem 10, 1, 1974.
29. Yu, Y.T., Breitbart, R.E., Smoot, L.B., Lee, Y., Mahdavi, V., and Nadal-Ginard, B. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev 6, 1783, 1992.
30. Di Lisi, R., Millino, C., Calabria, E., Altruda, F., Schiaffino, S., and Ausoni, S. Combinatorial cis-acting elements control tissue-specific activation of the cardiac troponin I gene in vitro and in vivo. J Biol Chem 273, 25371, 1998.
31. Arceci, R.J., King, A.A., Simon, M.C., Orkin, S.H., and Wilson, D.B. Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol Cell Biol 13, 2235, 1993.
32. Edmondson, D.G., Lyons, G.E., Martin, J.F., and Olson, E.N. Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development 120, 1251, 1994.
33. Fukuda, K. Molecular characterization of regenerated cardiomyocytes derived from adult mesenchymal stem cells. Congenital Anom 42, 1, 2002.
34. Akavia, U.D., Veinblat, O., and Benayahu, D. Comparing the transcriptional profile of mesenchymal cells to cardiac and skeletal muscle cells. J Cell Physiol 216, 663, 2008.
35. Dzamba, B.J., Wu, H., Jaenisch, R., and Peters, D.M. Fibronectin binding site in type I collagen regulates fibronectin fibril formation. J Cell Biol 121, 1165, 1993.
36. Engvall, E., Ruoslahti, E., and Miller, E.D. Affinity of fibronectin to collagens of different genetic types and to fibrinogen. J Exp Med 147, 1584, 1978.
37. James, C.W.C., and Chang, E.P. Dynamic mechanical and rheo-optical studies of collagen and gelatin. Biopolymers 11, 2015, 1972.
38. Engler, A.J., Griffin, M.A., Sen, S., Bönnemann, C.G., Sweeney, H.L., and Discher, D.E. Myotubes differentiate optimally on substrates with tissue-like stiffness: pathological implications for soft or stiff microenvironments. J Cell Biol 166, 877, 2004.
39. Engler, A.J., Sen, S., Sweeney, H.L., and Discher, D.E. Matrix elasticity directs stem cell lineage specification. Cell 126, 677, 2006.